Results 71 to 80 of about 1,706,119 (221)

Pharmacophore Modeling and 3D QSAR analysis of flavonoids and congeners active against A549 cell line

open access: yesInternational Journal of Research in Pharmaceutical Sciences, 2012
In our present study we have developed a ligand based 3D QSAR of 27 flavonoids and congeners active against human lung cancer cell line (A549) using the Phase module of Schrödinger suit.
Sudhan Debnath*   +3 more
doaj  

3D QSAR, pharmacophore indentification studies on series of 1-(2-ethoxyethyl)-1H-pyrazolo [4,3-d]pyrimidines as phosphodiesterase V inhibitors

open access: yesJournal of Saudi Chemical Society, 2015
Context: In recent years phosphodiesterase V acts as an attractive target for cardiovascular drug design and QSAR techniques are helpful for the optimization of structural requirements for designing novel compounds.
Prafulla Choudhari, Manish Bhatia
doaj   +1 more source

Optimisation of Topical and Transdermal Pharmaceutical Formulations: Methods, Challenges and Opportunities

open access: yesSmartSys, Volume 2, Issue 4, December 2026.
ABSTRACT Topical and transdermal pharmaceutical formulations are a large and diverse class of products, yet their optimisation remains a complex, resource‐intensive challenge. Statistical design‐of‐experiments approaches have long provided the methodological backbone for this process and have shown broad effectiveness across topical and transdermal ...
Yongrui Xiao   +5 more
wiley   +1 more source

Evaluating Thiram‐Induced Embryotoxicity Using Integrated In Silico, In Vitro, and Transcriptomic Approaches

open access: yesEnvironmental Toxicology, Volume 41, Issue 12, Page 1798-1812, December 2026.
ABSTRACT Long‐term exposure to low‐dose food contact materials (FCMs) has raised concerns regarding developmental toxicity. In the present study, we prioritized FCMs with potential developmental toxicity using a weight‐of‐evidence computational model, which predicted 127 chemicals to be of high concern.
Chia‐Chi Ho   +7 more
wiley   +1 more source

Drug Design and Discovery: The Long Road From Hansch Analysis to Artificial Intelligence

open access: yesChemMedChem, Volume 21, Issue 21, 12 November 2026.
The evolution of quantitative structure–activity relationships (QSAR) is traced from the pioneering work of Hansch to its contemporary applications in drug discovery. Key developments in multidimensional QSAR, multivariate statistical analysis and machine learning, model validation, and multi‐objective optimization are discussed.
Anna Tsantili‐Kakoulidou
wiley   +1 more source

GIFI-PLS: Modeling of Non-Linearities and Discontinuities in QSAR

open access: yes, 2000
This paper introduces to the QSAR community a novel method for modeling and understanding non-linear relationships between biological potency and chemical structure properties of molecules.
Lindgren, Fredrik   +3 more
core   +1 more source

Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 5, Page 1169-1172, November 2026.
Pediatric drug development has achieved remarkable success in the last 20 years with over 1,000 products studied in pediatric patients. This success has been driven in part by an increased understanding of pediatric disease processes. The aspect that has been largely overlooked is the potential adverse effect of new drugs on pediatric developmental ...
Gilbert J. Burckart   +6 more
wiley   +1 more source

2D and 3D quantitative structure-activity relationship studies on a series of bis-pyridinium compounds as choline kinase inhibitors

open access: yes, 2006
Two-dimensional (2D) and three-dimensional (3D) quantitative structure activity relationship (QSAR) studies have been carried out on a series of 55 bis-pyridinium compounds to find out the structural requirements of choline kinase (ChoK) inhibitors.
Sastry, G. Narahari   +2 more
core   +1 more source

3D-QSAR study of benzotriazol-1-yl carboxamide scaffold as monoacylglycerol lipase inhibitors

open access: yesJournal of Pharmacy and Bioallied Sciences, 2014
Purpose: The purpose of this study is to build up the 3D pharmacophore of Monoacylglycerol lipase (MAGL) inhibitor and to provide the basis to design the novel and potent MAGL inhibitors.
Obaid Afzal   +4 more
doaj   +1 more source

Advances in New Approach Methodologies at FDA's Division of Applied Regulatory Science

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 5, Page 1250-1254, November 2026.
New Approach Methodologies (NAMs) represent a paradigm shift in drug development and regulatory science, offering human‐relevant alternatives to traditional preclinical models. This mini‐review highlights recent advances in NAM development, validation, and regulatory application from FDA's Division of Applied Regulatory Science (DARS).
Ksenia Blinova   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy